Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
- PMID: 27733284
- PMCID: PMC5388856
- DOI: 10.1016/S0140-6736(16)31679-8
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Erratum in
-
Department of Error.Lancet. 2017 Jan 7;389(10064):e1. doi: 10.1016/S0140-6736(16)32632-0. Epub 2017 Jan 6. Lancet. 2017. PMID: 28091378 Free PMC article. No abstract available.
Abstract
Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context.
Methods: We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors-the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI).
Findings: Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6-58·8) of global deaths and 41·2% (39·8-42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa.
Interpretation: Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden.
Funding: Bill & Melinda Gates Foundation.
Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.
Figures
Comment in
-
Expanding GBD collaboration-call for experts in health financing and health systems.Lancet. 2017 Jan 7;389(10064):18-19. doi: 10.1016/S0140-6736(16)32569-7. Epub 2016 Dec 16. Lancet. 2017. PMID: 27989559 No abstract available.
Similar articles
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496105 Free PMC article.
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8. Lancet. 2017. PMID: 28919119 Free PMC article.
-
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4. Lancet. 2024. PMID: 38762324 Free PMC article.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
-
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1564-74. doi: 10.1016/S0140-6736(13)61530-5. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993281 Review.
Cited by
-
Improvement in Nutritional Knowledge Confidence and Food-Agency: Outcomes of the First French-Speaking Culinary Medicine Courses Among Medical Students.Am J Lifestyle Med. 2024 May 7:15598276241252612. doi: 10.1177/15598276241252612. Online ahead of print. Am J Lifestyle Med. 2024. PMID: 39554969 Free PMC article.
-
Mitigating household air pollution exposure through kitchen renovation.Environ Sci Ecotechnol. 2024 Oct 22;23:100501. doi: 10.1016/j.ese.2024.100501. eCollection 2025 Jan. Environ Sci Ecotechnol. 2024. PMID: 39553849 Free PMC article.
-
Combined effect of triglyceride glucose-body mass index and hypertension on new-onset stroke: evidence from the China health and retirement longitudinal study.Front Public Health. 2024 Oct 25;12:1432742. doi: 10.3389/fpubh.2024.1432742. eCollection 2024. Front Public Health. 2024. PMID: 39525457 Free PMC article.
-
Development of a Method to Determine the Environmental Burden of Diseases and an Application to Identify Factors Driving Changes in the Number of PM2.5-Related Deaths in China between 2000 and 2010.Environ Health (Wash). 2024 Jun 12;2(9):642-650. doi: 10.1021/envhealth.4c00048. eCollection 2024 Sep 20. Environ Health (Wash). 2024. PMID: 39512395 Free PMC article.
-
Cost-effectiveness of tax policies on promoting sustainable diets in Iran: a modeling study.Front Nutr. 2024 Oct 21;11:1453969. doi: 10.3389/fnut.2024.1453969. eCollection 2024. Front Nutr. 2024. PMID: 39498406 Free PMC article.
References
-
- Public Health England . From evidence into action: opportunities to protect and improve the nation's health. Public Health England; London: 2014.
-
- Institute for Health Metrics and Evaluation President Ian Khama: emboldened by evidence to reduce harms of alcohol use in Botswana. http://www.healthdata.org/acting-data/president-ian-khama-emboldened-evi... (accessed July 24, 2016).
-
- GBD 2013 Risk Factors Collaborators. Forouzanfar MH, Alexander L. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–2323. - PMC - PubMed
-
- Kellerborg K, Danielsson AK, Allebeck P, Coates MM, Agardh E. Disease burden attributed to alcohol: how methodological advances in the Global Burden of Disease 2013 Study have changed the estimates in Sweden. Scand J Public Health. 2016;44:604–610. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MR/K010174/1/MRC_/Medical Research Council/United Kingdom
- R21 AG032572/AG/NIA NIH HHS/United States
- P01 HD031921/HD/NICHD NIH HHS/United States
- 095066/WT_/Wellcome Trust/United Kingdom
- IAG BSR06-11/US/United States/United States
- Y1 AG-4553-01 /US/United States/United States
- IA/CPHI/14/1/501514/WTDBT_/DBT-Wellcome Trust India Alliance/India
- P30 ES000260/ES/NIEHS NIH HHS/United States
- GNT1042600/US/United States/United States
- 21133/CRUK_/Cancer Research UK/United Kingdom
- R01 AG030153/AG/NIA NIH HHS/United States
- U01 AG09740-13S2/US/United States/United States
- P01 AG008291/AG/NIA NIH HHS/United States
- P30 AG012815/AG/NIA NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R21 AG025169/AG/NIA NIH HHS/United States
- OGHA 04-064/US/United States/United States
- P01 AG005842/AG/NIA NIH HHS/United States
- RP-PG-0407-10184/DH_/Department of Health/United Kingdom
- R03 AG043052/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous